Stay updated with breaking news from Antipsychotics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pimavanserin, a novel antipsychotic drug used to manage hallucinations and delusions in Parkinson's disease, is linked to increased hospitalizations and mortality, new research suggests.
Researchers question the long-term use of antipsychotics and suggest increased research and investment in psychosocial interventions.
Pharmaceutical Society of Australia PSA welcomes the Morrison Government’s announcement on women’s health, mental health and aged care sector following tonight’s Federal Budget. The Government has announced it will commit $17.7bn on aged care along with $1.9bn in additional funding for COVID-19 vaccine program. A commitment has also been made to extend funding to the take-home naloxone pilot. Pharmaceutical Society of Australia National President, A/Prof Chris Freeman, commended the Federal Government for their decision, but says more must be done to safeguard residents from the harms m...
Abstract The antipsychotic drug olanzapine is associated with serious obesity side effects. Hypothalamic astrocytes and associated toll-like receptor-4 (TLR4) signaling play an essential role in obesity pathogenesis. This study investigated the effect of olanzapine on astrocytes and TLR4 signaling both in vitro and in the rat hypothalamus and their potential role in olanzapine-induced weight gain. We found that olanzapine treatment for 24 h dose-dependently increased cell viability, increased the protein expression of astrocyte markers including glial fibrillary acidic protein (GFAP) and S100...
Photo Credit: IANS IANSLive London, April 12 (IANS) Patients treated with antipsychotic drugs have a lower risk of becoming infected or suffer a milder form of SARS-CoV-2 -- the virus causing Covid-19 -- if they get infected, according to a study. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 12-April-2021